Investigative Site

Frankfurt 60590

0 studies enrolling now · 5 studies all time

What they study most

Essential Hypertension, Hepatitis B, Chronic, Hepatitis C, Rheumatoid Arthritis, Viral Hepatitis

Studies at this site

• Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection — Completed
• A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection — Running, not enrolling
• GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy — Completed
• Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects — Completed
• Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension. — Completed